These evidences support SOX2 as a prospective biomarker for cancer stemness in this sense that even if there were numerous CSC markers, such as cell surface marker CD15 (stage-specific embryonic antigen 1), very few of them had been demonstrated to actively promote stem-like properties. The gene discussed is FUT4; the disease is cancer.